文献速递重症综合管理与镇静镇痛儿科与产科急症

门诊心理健康随访与因自伤入住ICU患者再次自伤及自杀的关系:一项基于人群的队列研究

Outpatient Mental Health Follow-up and Recurrent Self-harm and Suicide Among Patients Admitted to the ICU for Self-harm: A Population-based Cohort Study.
PubMed 文献 · Chest · 2022-10-29
一句话结论因故意自伤入住ICU的成人出院后接受心理健康随访(无论是早期还是晚期)与再次因自伤入住ICU风险升高相关,而非降低。

这项基于加拿大安大略省的人群队列研究纳入2009至2017年间因故意自伤入住ICU的连续成人患者9569例,按出院后心理健康随访时间分为早期随访(出院后1至21天)、晚期随访(22至60天)和无随访(60天内无随访)。采用病因特异性扩展Cox回归模型分析,主要结局为出院1年内再次因自伤入住ICU。结果显示,与无随访相比,早期随访(HR 1.37;95%CI 1.07-1.75)和晚期随访(HR 1.69;95%CI 1.22-2.35)均与再次因自伤入住ICU风险升高相关;自杀死亡方面,早期随访(HR 1.10;95%CI 0.70-1.73)和晚期随访(HR 1.54;95%CI 0.84-2.83)均未达统计学显著。作者认为,出院后心理健康随访未降低再次自伤入住ICU或自杀死亡风险,寻求门诊随访的患者可能是这些结局的最高危人群。

要点

  • 与无心理健康随访相比,出院后1至21天早期随访(HR 1.37;95%CI 1.07-1.75)和22至60天晚期随访(HR 1.69;95%CI 1.22-2.35)均与再次因自伤入住ICU风险升高相关。
  • 与无随访相比,早期随访(HR 1.10;95%CI 0.70-1.73)和晚期随访(HR 1.54;95%CI 0.84-2.83)与自杀死亡风险升高均未达统计学显著。
  • 研究纳入2009至2017年加拿大安大略省因故意自伤入住ICU的连续成人9569例,主要结局为出院1年内再次因自伤入住ICU。
  • 作者认为,寻求门诊随访的患者可能是再次自伤入住ICU或自杀死亡的最高危人群,未来研究应聚焦于这一脆弱人群的额外和新型风险缓解方法。

适用人群与场景

  • 2009至2017年加拿大安大略省因故意自伤入住ICU的连续成人患者(≥18岁)。

诊断标准与关键阈值

  • 早期随访:出院后1至21天接受心理健康随访(由家庭医生或精神科医生);晚期随访:出院后22至60天;无随访:出院后60天内无随访。

研究设计与关键结果

  • 研究类型:基于人群的队列研究;样本量:9569例连续成人;人群:因故意自伤入住ICU者;暴露:出院后心理健康随访(早期1-21天、晚期22-60天)vs 无随访(60天内无随访);主要终点:出院1年内再次因自伤入住ICU。
  • 与无随访相比,早期随访(HR 1.37;95%CI 1.07-1.75)和晚期随访(HR 1.69;95%CI 1.22-2.35)均与再次因自伤入住ICU风险升高相关。
  • 与无随访相比,早期随访(HR 1.10;95%CI 0.70-1.73)和晚期随访(HR 1.54;95%CI 0.84-2.83)与自杀死亡风险升高均未达统计学显著。

证据类型、等级与局限

  • 证据类型:基于人群的队列研究;采用病因特异性扩展Cox回归模型。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,出院后心理健康随访未降低再次因自伤入住ICU或自杀死亡风险,寻求门诊随访的患者可能是这些结局的最高危人群。
  • 作者认为,未来研究应聚焦于这一脆弱人群的额外和新型风险缓解方法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients surviving an ICU admission for deliberate self-harm are at high risk of recurrent self-harm or suicide after discharge. It is unknown whether mental health follow-up after discharge (with either a family physician or psychiatrist) reduces this risk.

RESEARCH QUESTION: What is the association between mental health follow-up after discharge and recurrent self-harm among patients admitted to the ICU for intentional self-harm?

STUDY DESIGN AND METHODS: Population-based cohort study of consecutive adults (≥ 18 years of age) from Ontario, Canada, who were admitted to ICU because of intentional self-harm between 2009 and 2017. We categorized patients according to follow-up, with 'early follow-up' indicating 1 to 21 days after discharge, 'late follow-up' indicating 22 to 60 days after discharge, and 'no follow-up' indicating no follow-up within 60 days of discharge. We conducted analyses using a cause-specific extended Cox regression model to account for varying time for mental health follow-up relative to the outcomes of interest. The primary outcome was recurrent ICU admission for self-harm within 1 year of discharge.

RESULTS: We included 9,569 consecutive adults admitted to the ICU for deliberate self-harm. Compared with receiving no mental health follow-up, both early follow-up (hazard ratio [HR], 1.37; 95% CI, 1.07-1.75) and late follow-up (HR, 1.69; 95% CI, 1.22-2.35) were associated with increased risk in recurrent ICU admission for self-harm. As compared with no follow-up, neither early follow-up (HR, 1.10; 95% CI, 0.70-1.73) nor late follow-up (HR, 1.54; 95% CI, 0.84-2.83) were associated with increased risk of death by suicide.

INTERPREATION: Among adults admitted to the ICU for deliberate self-harm, mental health follow-up after discharge was not associated with reduced risk of recurrent ICU admission for self-harm or death resulting from suicide, and patients seeking outpatient follow-up may be those at highest risk of these outcomes. Future research should focus on additional and novel methods of risk mitigation in this vulnerable population.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Fernando SM, Pugliese M, McIsaac DI, et al. Outpatient Mental Health Follow-up and Recurrent Self-harm and Suicide Among Patients Admitted to the ICU for Self-harm: A Population-based Cohort Study. Chest. 2022. PMID: 36445799. doi:10.1016/j.chest.2022.10.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。